Francisco Silva, VP of Research and Development at BioRestorative Therapies, Inc. (BRTX), bought 4,295 shares at $0.21 ($19K) on 2013-07-17, disclosed to the SEC on 2017-03-01.
Open-market purchase of $19k BRTX by VP of Research and Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.21 | 50 | $10 | 0.1% |
| 2 | $10.40 | 50 | $520 | 2.7% |
| 3 | $10.40 | 100 | $1K | 5.4% |
| 4 | $7.60 | 25 | $190 | 1.0% |
| 5 | $7.60 | 20 | $152 | 0.8% |
| 6 | $4.25 | 2,250 |
| $10K |
| 49.4% |
| 7 | $4.38 | 1,800 | $8K | 40.7% |
| Total | $4.51 avg | 4,295 | $19K | 100% |
| Filing → |
| BRTX | BUY | 2023-04-04 | $3K | — | Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |